Conferences
10–11 September 2012, Berlin, Germany
Biomarkers in Drug Discovery & Developmentwith
With the increase of biomarkers application since the beginning of the 21st century, we are now not only seeing a great potential in improving the efficiency and safety of drug development, but we are also coming across some barriers which may slow these processes down.
To answer the challenges connected with utilization of biomarkers, we bring together the pharmaceutical minds along with representatives from academia, research institutions and non-profit organizations.
Two focused conference days offer case studies exploiting the best practices inaccelerating the identification of biomarkers, cutting the costs of attrition of compounds, reducing the size, cost and duration of clinical trials as well as the possibility of adverse events.
